MiR-638 acts as a tumor suppressor gene in gastric cancer

Gastric cancer is one of the major causes of cancer mortality. Several microRNAs play a role in the tumor growth and invasion. However, the underlying molecular mechanism remains poorly understood. We detected the miR-638 expression levels in tumor samples and adjacent noncancerous tissues from 68 p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget 2017-12, Vol.8 (64), p.108170-108180
Hauptverfasser: Shen, Yu, Chen, Haiqun, Gao, Ling, Zhang, Weigang, He, Jun, Yang, Xiaohua, Qin, Lei, Xue, Xiaofeng, Guo, Zhaoji
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 108180
container_issue 64
container_start_page 108170
container_title Oncotarget
container_volume 8
creator Shen, Yu
Chen, Haiqun
Gao, Ling
Zhang, Weigang
He, Jun
Yang, Xiaohua
Qin, Lei
Xue, Xiaofeng
Guo, Zhaoji
description Gastric cancer is one of the major causes of cancer mortality. Several microRNAs play a role in the tumor growth and invasion. However, the underlying molecular mechanism remains poorly understood. We detected the miR-638 expression levels in tumor samples and adjacent noncancerous tissues from 68 patients with gastric cancer as well as in the gastric cancer cell line SGC-7901 and SC-M1. The cell cycle was analyzed by flow cytometry, cell proliferation was observed by CCK-8 assay and cell invasion was detected using Transwell assay. MiR-638 was down-regulated in human GC tissues and its expression level was negatively correlated to TNM stage and lymph metastasis. In the cell lines, aberrant expression of miR-638 was related to the cell proliferation, cell cycle and invasion. We also found that SOX2 had a negative correlation with miR-638 in GC tissues, and miR-638 overexpression could decrease SOX2 expression level by directly binding the 3'-UTR of SOX2. , down-regulating SOX2 by siRNA could counteract the effect of miR-638 inhibitor on GC cells proliferation and invasion. Our results demonstrate that miR-638 may play a pivotal role in the growth and invasion of GC.
doi_str_mv 10.18632/oncotarget.22567
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5746134</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1984257628</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-aacbb072284630196ce2479a273cc7305c68ebaf4695d3d037f7ca6a5818e8ec3</originalsourceid><addsrcrecordid>eNpVUE1Lw0AQXUSxpfYHeJEcvaRmd7NfF0GKX1ARRM_LZjuJkSQbdzeC_97Q1lqHgXkw770ZHkLnOFtgySm5cp110fgK4oIQxsURmmKVq5QwRo8P8ATNQ_jIxmK5kESdoglRRHFCyRSpp_ol5VQmxsaQmLGTOLTOJ2Hoew8hjLCCDpK6SyoToq9tYk1nwZ-hk9I0Aea7OUNvd7evy4d09Xz_uLxZpZYqFVNjbFFkghCZc5phxS2QXChDBLVW0IxZLqEwZc4VW9N1RkUprOGGSSxBgqUzdL317YeihbWFLnrT6N7XrfHf2pla_9909buu3JdmIueY5qPB5c7Au88BQtRtHSw0jenADUFjJXPCBCdypOIt1XoXgodyfwZnepO6_ktdb1IfNReH_-0VvxnTH6CHgDU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1984257628</pqid></control><display><type>article</type><title>MiR-638 acts as a tumor suppressor gene in gastric cancer</title><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free E- Journals</source><creator>Shen, Yu ; Chen, Haiqun ; Gao, Ling ; Zhang, Weigang ; He, Jun ; Yang, Xiaohua ; Qin, Lei ; Xue, Xiaofeng ; Guo, Zhaoji</creator><creatorcontrib>Shen, Yu ; Chen, Haiqun ; Gao, Ling ; Zhang, Weigang ; He, Jun ; Yang, Xiaohua ; Qin, Lei ; Xue, Xiaofeng ; Guo, Zhaoji</creatorcontrib><description>Gastric cancer is one of the major causes of cancer mortality. Several microRNAs play a role in the tumor growth and invasion. However, the underlying molecular mechanism remains poorly understood. We detected the miR-638 expression levels in tumor samples and adjacent noncancerous tissues from 68 patients with gastric cancer as well as in the gastric cancer cell line SGC-7901 and SC-M1. The cell cycle was analyzed by flow cytometry, cell proliferation was observed by CCK-8 assay and cell invasion was detected using Transwell assay. MiR-638 was down-regulated in human GC tissues and its expression level was negatively correlated to TNM stage and lymph metastasis. In the cell lines, aberrant expression of miR-638 was related to the cell proliferation, cell cycle and invasion. We also found that SOX2 had a negative correlation with miR-638 in GC tissues, and miR-638 overexpression could decrease SOX2 expression level by directly binding the 3'-UTR of SOX2. , down-regulating SOX2 by siRNA could counteract the effect of miR-638 inhibitor on GC cells proliferation and invasion. Our results demonstrate that miR-638 may play a pivotal role in the growth and invasion of GC.</description><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.22567</identifier><identifier>PMID: 29296232</identifier><language>eng</language><publisher>United States: Impact Journals LLC</publisher><subject>Research Paper</subject><ispartof>Oncotarget, 2017-12, Vol.8 (64), p.108170-108180</ispartof><rights>Copyright: © 2017 Shen et al. 2017</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-aacbb072284630196ce2479a273cc7305c68ebaf4695d3d037f7ca6a5818e8ec3</citedby><cites>FETCH-LOGICAL-c399t-aacbb072284630196ce2479a273cc7305c68ebaf4695d3d037f7ca6a5818e8ec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746134/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746134/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,27907,27908,53774,53776</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29296232$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shen, Yu</creatorcontrib><creatorcontrib>Chen, Haiqun</creatorcontrib><creatorcontrib>Gao, Ling</creatorcontrib><creatorcontrib>Zhang, Weigang</creatorcontrib><creatorcontrib>He, Jun</creatorcontrib><creatorcontrib>Yang, Xiaohua</creatorcontrib><creatorcontrib>Qin, Lei</creatorcontrib><creatorcontrib>Xue, Xiaofeng</creatorcontrib><creatorcontrib>Guo, Zhaoji</creatorcontrib><title>MiR-638 acts as a tumor suppressor gene in gastric cancer</title><title>Oncotarget</title><addtitle>Oncotarget</addtitle><description>Gastric cancer is one of the major causes of cancer mortality. Several microRNAs play a role in the tumor growth and invasion. However, the underlying molecular mechanism remains poorly understood. We detected the miR-638 expression levels in tumor samples and adjacent noncancerous tissues from 68 patients with gastric cancer as well as in the gastric cancer cell line SGC-7901 and SC-M1. The cell cycle was analyzed by flow cytometry, cell proliferation was observed by CCK-8 assay and cell invasion was detected using Transwell assay. MiR-638 was down-regulated in human GC tissues and its expression level was negatively correlated to TNM stage and lymph metastasis. In the cell lines, aberrant expression of miR-638 was related to the cell proliferation, cell cycle and invasion. We also found that SOX2 had a negative correlation with miR-638 in GC tissues, and miR-638 overexpression could decrease SOX2 expression level by directly binding the 3'-UTR of SOX2. , down-regulating SOX2 by siRNA could counteract the effect of miR-638 inhibitor on GC cells proliferation and invasion. Our results demonstrate that miR-638 may play a pivotal role in the growth and invasion of GC.</description><subject>Research Paper</subject><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVUE1Lw0AQXUSxpfYHeJEcvaRmd7NfF0GKX1ARRM_LZjuJkSQbdzeC_97Q1lqHgXkw770ZHkLnOFtgySm5cp110fgK4oIQxsURmmKVq5QwRo8P8ATNQ_jIxmK5kESdoglRRHFCyRSpp_ol5VQmxsaQmLGTOLTOJ2Hoew8hjLCCDpK6SyoToq9tYk1nwZ-hk9I0Aea7OUNvd7evy4d09Xz_uLxZpZYqFVNjbFFkghCZc5phxS2QXChDBLVW0IxZLqEwZc4VW9N1RkUprOGGSSxBgqUzdL317YeihbWFLnrT6N7XrfHf2pla_9909buu3JdmIueY5qPB5c7Au88BQtRtHSw0jenADUFjJXPCBCdypOIt1XoXgodyfwZnepO6_ktdb1IfNReH_-0VvxnTH6CHgDU</recordid><startdate>20171208</startdate><enddate>20171208</enddate><creator>Shen, Yu</creator><creator>Chen, Haiqun</creator><creator>Gao, Ling</creator><creator>Zhang, Weigang</creator><creator>He, Jun</creator><creator>Yang, Xiaohua</creator><creator>Qin, Lei</creator><creator>Xue, Xiaofeng</creator><creator>Guo, Zhaoji</creator><general>Impact Journals LLC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20171208</creationdate><title>MiR-638 acts as a tumor suppressor gene in gastric cancer</title><author>Shen, Yu ; Chen, Haiqun ; Gao, Ling ; Zhang, Weigang ; He, Jun ; Yang, Xiaohua ; Qin, Lei ; Xue, Xiaofeng ; Guo, Zhaoji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-aacbb072284630196ce2479a273cc7305c68ebaf4695d3d037f7ca6a5818e8ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Research Paper</topic><toplevel>online_resources</toplevel><creatorcontrib>Shen, Yu</creatorcontrib><creatorcontrib>Chen, Haiqun</creatorcontrib><creatorcontrib>Gao, Ling</creatorcontrib><creatorcontrib>Zhang, Weigang</creatorcontrib><creatorcontrib>He, Jun</creatorcontrib><creatorcontrib>Yang, Xiaohua</creatorcontrib><creatorcontrib>Qin, Lei</creatorcontrib><creatorcontrib>Xue, Xiaofeng</creatorcontrib><creatorcontrib>Guo, Zhaoji</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncotarget</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shen, Yu</au><au>Chen, Haiqun</au><au>Gao, Ling</au><au>Zhang, Weigang</au><au>He, Jun</au><au>Yang, Xiaohua</au><au>Qin, Lei</au><au>Xue, Xiaofeng</au><au>Guo, Zhaoji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MiR-638 acts as a tumor suppressor gene in gastric cancer</atitle><jtitle>Oncotarget</jtitle><addtitle>Oncotarget</addtitle><date>2017-12-08</date><risdate>2017</risdate><volume>8</volume><issue>64</issue><spage>108170</spage><epage>108180</epage><pages>108170-108180</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><abstract>Gastric cancer is one of the major causes of cancer mortality. Several microRNAs play a role in the tumor growth and invasion. However, the underlying molecular mechanism remains poorly understood. We detected the miR-638 expression levels in tumor samples and adjacent noncancerous tissues from 68 patients with gastric cancer as well as in the gastric cancer cell line SGC-7901 and SC-M1. The cell cycle was analyzed by flow cytometry, cell proliferation was observed by CCK-8 assay and cell invasion was detected using Transwell assay. MiR-638 was down-regulated in human GC tissues and its expression level was negatively correlated to TNM stage and lymph metastasis. In the cell lines, aberrant expression of miR-638 was related to the cell proliferation, cell cycle and invasion. We also found that SOX2 had a negative correlation with miR-638 in GC tissues, and miR-638 overexpression could decrease SOX2 expression level by directly binding the 3'-UTR of SOX2. , down-regulating SOX2 by siRNA could counteract the effect of miR-638 inhibitor on GC cells proliferation and invasion. Our results demonstrate that miR-638 may play a pivotal role in the growth and invasion of GC.</abstract><cop>United States</cop><pub>Impact Journals LLC</pub><pmid>29296232</pmid><doi>10.18632/oncotarget.22567</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1949-2553
ispartof Oncotarget, 2017-12, Vol.8 (64), p.108170-108180
issn 1949-2553
1949-2553
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5746134
source PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free E- Journals
subjects Research Paper
title MiR-638 acts as a tumor suppressor gene in gastric cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T04%3A59%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MiR-638%20acts%20as%20a%20tumor%20suppressor%20gene%20in%20gastric%20cancer&rft.jtitle=Oncotarget&rft.au=Shen,%20Yu&rft.date=2017-12-08&rft.volume=8&rft.issue=64&rft.spage=108170&rft.epage=108180&rft.pages=108170-108180&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.22567&rft_dat=%3Cproquest_pubme%3E1984257628%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1984257628&rft_id=info:pmid/29296232&rfr_iscdi=true